Ingevity partners with Ultrapolymers Group for European sales of Capa® caprolactone Bioplastics
“Adding a new distribution partner within
“We are excited to add Ingevity to our portfolio of suppliers for the thermoplastics market,” said David Viehoff, management team at Ultrapolymers Group. “Ingevity’s portfolio of Capa caprolactone bioplastics aligns with our goal of offering the most advanced, innovative and sustainable materials to our customers.”
Ingevity: Purify, Protect, Enhance
Ingevity provides products and technologies that purify, protect and enhance the world around us. Through a team of talented and experienced people, we develop, manufacture and bring to market solutions that help customers solve complex problems and make the world more sustainable. We operate in three reporting segments: Performance Materials, which includes activated carbon; Advanced Polymer Technologies, which includes caprolactone polymers; and Performance Chemicals, which includes specialty chemicals and road technologies. Our products are used in a variety of demanding applications, including adhesives, agrochemicals, asphalt paving, certified biodegradable bioplastics, coatings, elastomers, lubricants, pavement markings, oil exploration and production and automotive components. Headquartered in
Ultrapolymers Group
Ultrapolymers Group is one of the leading pan-European distributors with over 20 years of experience in the industry. The company’s product portfolio is designed to meet customers’ needs across a wide range of industries, including automotive, aerospace, electrical, electronics, healthcare, packaging and consumer goods, with technical expertise and value-added services. As the company looks toward the future, it remains committed to sustainable and responsible business practices delivering solutions that empower businesses to thrive. Find out more information at www.ultrapolymers.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240709368624/en/
Caroline Monahan
843-740-2068
caroline.monahan@ingevity.com
Investors:
John E. Nypaver, Jr.
843-740-2002
investors@ingevity.com
Source: Ingevity Corporation